Inhibition of MAP kinase kinase causes morphological reversion and dissociation between soft agar growth and in vivo tumorigenesis in angiosarcoma cells

American Journal of Pathology

Volumn 157, Issue 6, 2000, Pages 1937-1945

  LaMontagne, Kenneth R ^a   Moses, Marsha A ^a   Wiederschain, Dmitri ^a   Mahajan, Sudipta ^b   Holden, Jeannine ^c   Ghazizadeh, Hamid ^a   Frank, David A ^b   Arbiser, Jack L ^c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PHOSPHATIDYLINOSITOL 3 KINASE;

ANGIOSARCOMA; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; FIBROBLAST; GENETIC TRANSFECTION; IN VIVO STUDY; MOUSE; MULTIGENE FAMILY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SARCOMA CELL; SIGNAL TRANSDUCTION; TEMPERATURE SENSITIVE MUTANT; TUMOR GROWTH;

EID: 0033635223     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64832-8     Document Type: Article

References (32)

1. Phosphoinositol-3-OH kinase as a direct target of ras
2. Stimulation of membrane ruffling and MAP kinase activation by distinct effectors of ras
3. Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for ras transformation
4. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation and for transformation of NIH 3T3 cells
5. Transformation of mammalian cells by constitutively active MAP kinase kinase
6. Suppression of c-myc induced apoptosis by ras signalling through PI(3)K and PKB
7. Matrix adhesion and ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway
8. Mitogen activated protein kinase/extracellular signal-regulated protein kinase activation by oncogenes, serum, and 12-O-tetradecanoylphorbol-13-acetate requires raf and is necessary for transformation
9. Mutant ras oncogenes upregulate VEGF/VPF expression: Implications for induction and inhibition of tumor angiogenesis
10. Both v-Ha-ras and v-raf stimulate the expression of the vascular endothelial growth factor in NIH3T3 cells
11. Oncogenic H-Ras stimulates tumor angiogenesis by two distinct pathways
12. Thyroid hormone receptor b1 expression in developing mouse limbs and face
13. Insulin-like growth factor-1 mediated neurite outgrowth in vitro requires mitogen-activated protein kinase activation
14. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
15. Protein tyrosine phosphatase PTP1B suppresses p210 bcr-abl induced transformation of Rat1 fibroblasts and promotes differentiation of K562 cells
16. Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation
17. Deletion and altered regulation of p16ink4a and p15ink4b in undifferentiated mouse skin tumors
18. An essential role for Rac in ras transformation
19. Ras, but not src transformation of RIE-1 epithelial cells is dependent on activation of the mitogen-activated protein kinase cascade
20. Activation of the Raf-1/MAP kinase cascade is not sufficient for Ras transformation of RIE-1 epithelial cells
21. Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase
22. Raf-induced proliferation or cell cycle arrest is determined by the level of raf activity with arrest mediated by p21Cip1
23. Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway
24. Signal transduction pathways regulated by mitogen-activated/extracellular response kinase kinase kinase induce cell death
25. Integrins and anoikis
26. The bcr-abl oncogene transforms rat-1 cells and cooperates with v-myc
27. Suspension culture for the selective assay of cells transformed by polyoma virus
28. Anchorage and growth regulation in normal and virus-transformed cells
29. Tumorigenicity of virus transformed cells in nude mice is correlated specifically with anchorage-independent growth in vitro
30. Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention
31. Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor
32. Differential expression of active MAP kinase in cutaneous endothelial neoplasms: Implications for biologic behavior and response to therapy